Letter: can persisting liver stiffness indicate increased risk for HCC, after successful anti-HCV therapy? - authors' reply

Aliment Pharmacol Ther. 2016 Feb;43(4):544-5. doi: 10.1111/apt.13494.

Authors

M Mandorfer^{1

2}, K Kozbial¹, M Peck-Radosavljevic^{1

2}, P Ferenci³

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
² Vienna Hepatic Hemodynamic Lab, Vienna, Austria.
³ Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria. [email protected].

PMID: 26753821
DOI: 10.1111/apt.13494

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents / therapeutic use*
Female
Hepatitis C, Chronic / complications*
Hepatitis C, Chronic / drug therapy*
Humans
Hypertension, Portal / etiology*
Liver / physiopathology*
Liver Cirrhosis / drug therapy*
Liver Cirrhosis / etiology*
Male
Portal Pressure / drug effects*

Substances

Antiviral Agents